Bristol Myers Squibb BMY
NYSE BMY
$63.03 +0.20 (+0.32%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Prepaid Assets (2009 - 2026)

Bristol Myers Squibb's (BMY) quarterly Prepaid Assets came in at $4.2 billion in Q2 2026, down 22.76% year-over-year from $5.5 billion in Q2 2025, and down 8.16% quarter-over-quarter from $4.6 billion in Q1 2026.

Analysis

Bristol Myers Squibb (BMY) Prepaid Assets (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Prepaid Assets for 18 consecutive years, with $4.2 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 22.76% year-over-year to $4.2 billion in Q2 2026; TTM through Jun 2026 was $4.2 billion, a 22.76% decrease from a year earlier, with the FY2025 full-year figure at $4.6 billion, down 17.87% from the prior year.
  • Prepaid Assets was $4.2 billion for Q2 2026 at Bristol Myers Squibb, down from $4.6 billion in the prior quarter.
  • Over five years, Prepaid Assets peaked at $7.2 billion in Q3 2023 and troughed at $4.2 billion in Q2 2026.
  • A 5-year average of $5.5 billion and a median of $5.6 billion in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets surged 39.11% in 2022 and retreated 22.76% in 2026, its largest moves.
  • Over 5 years, Prepaid Assets stood at $5.8 billion in 2022, then grew by 1.93% to $5.9 billion in 2023, then fell by 4.91% to $5.6 billion in 2024, then decreased by 17.87% to $4.6 billion in 2025, then declined by 8.48% to $4.2 billion in 2026.
  • The last three Prepaid Assets figures came in at $4.2 billion (Q2 2026), $4.6 billion (Q1 2026), and $4.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.22 Bn
Mar 31, 2026 4.60 Bn
Dec 31, 2025 4.61 Bn
Sep 30, 2025 4.95 Bn
Jun 30, 2025 5.47 Bn
Mar 31, 2025 5.53 Bn
Dec 31, 2024 5.62 Bn
Sep 30, 2024 5.62 Bn
Jun 30, 2024 5.74 Bn
Mar 31, 2024 5.57 Bn
Dec 31, 2023 5.91 Bn
Sep 30, 2023 7.21 Bn
Jun 30, 2023 6.87 Bn
Mar 31, 2023 5.16 Bn
Dec 31, 2022 5.80 Bn
Sep 30, 2022 6.08 Bn
Jun 30, 2022 5.76 Bn
Mar 31, 2022 4.54 Bn
Dec 31, 2021 4.83 Bn
Sep 30, 2021 4.37 Bn